cilostazol has been researched along with Gastrointestinal Hemorrhage in 5 studies
Gastrointestinal Hemorrhage: Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin is widely used for secondary prevention after stroke." | 8.87 | Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. ( Husain, MR; Kamal, AK; Khealani, BA; Naqvi, I, 2011) |
| "We compared the efficacy and safety of cilostazol and aspirin in 2,672 Japanese patients with non-cardioembolic ischemic stroke." | 8.86 | [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients]. ( Uchiyama, S, 2010) |
| " Patients with diagnosis codes for ischemic stroke without cardiac disease were included and divided into two groups, those receiving cilostazol and those receiving clopidogrel." | 8.31 | Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. ( Je, NK; Lee, YJ, 2023) |
| "Aspirin is widely used for secondary prevention after stroke." | 4.87 | Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. ( Husain, MR; Kamal, AK; Khealani, BA; Naqvi, I, 2011) |
| "We compared the efficacy and safety of cilostazol and aspirin in 2,672 Japanese patients with non-cardioembolic ischemic stroke." | 4.86 | [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients]. ( Uchiyama, S, 2010) |
| "Replacement of thienopyridine with aspirin or cilostazol may be acceptable for minimizing both the risk of post-ESD bleeding and thromboembolism in patients with EGC." | 4.31 | Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. ( Asahina, Y; Fujishiro, M; Hasatani, K; Hatta, W; Hayashi, Y; Hikichi, T; Hoteya, S; Iguchi, M; Inoue, T; Kikuchi, D; Kiyotoki, S; Kobayashi, M; Kuribayashi, S; Mabe, K; Masamune, A; Matsumura, T; Michida, T; Mikami, T; Miura, Y; Morita, Y; Nagami, Y; Nakamatsu, D; Narasaka, T; Nebiki, H; Nishikawa, J; Ohnita, K; Sugimoto, M; Sumiyoshi, T; Suzuki, H; Tomida, H; Tsuji, S; Tsuji, Y; Ueyama, H; Yabuuchi, Y; Yada, T; Yamaguchi, S; Yoshio, T, 2023) |
| " Patients with diagnosis codes for ischemic stroke without cardiac disease were included and divided into two groups, those receiving cilostazol and those receiving clopidogrel." | 4.31 | Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. ( Je, NK; Lee, YJ, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, Y | 1 |
| Tsuji, Y | 1 |
| Yoshio, T | 1 |
| Hatta, W | 1 |
| Yabuuchi, Y | 1 |
| Hoteya, S | 1 |
| Kikuchi, D | 1 |
| Tsuji, S | 1 |
| Nagami, Y | 1 |
| Hikichi, T | 1 |
| Kobayashi, M | 1 |
| Morita, Y | 1 |
| Sumiyoshi, T | 1 |
| Iguchi, M | 1 |
| Tomida, H | 1 |
| Inoue, T | 1 |
| Mikami, T | 1 |
| Hasatani, K | 1 |
| Nishikawa, J | 1 |
| Matsumura, T | 1 |
| Nebiki, H | 1 |
| Nakamatsu, D | 1 |
| Ohnita, K | 1 |
| Suzuki, H | 1 |
| Ueyama, H | 1 |
| Hayashi, Y | 1 |
| Sugimoto, M | 1 |
| Yamaguchi, S | 1 |
| Michida, T | 1 |
| Yada, T | 1 |
| Asahina, Y | 1 |
| Narasaka, T | 1 |
| Kuribayashi, S | 1 |
| Kiyotoki, S | 1 |
| Mabe, K | 1 |
| Masamune, A | 1 |
| Fujishiro, M | 1 |
| Lee, YJ | 1 |
| Je, NK | 1 |
| Yasuda, H | 1 |
| Yamada, M | 1 |
| Sawada, S | 1 |
| Endo, Y | 1 |
| Inoue, K | 1 |
| Asano, F | 1 |
| Takeyama, Y | 1 |
| Yoshiba, M | 1 |
| Kamal, AK | 1 |
| Naqvi, I | 1 |
| Husain, MR | 1 |
| Khealani, BA | 1 |
| Uchiyama, S | 1 |
2 reviews available for cilostazol and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
Topics: Asian People; Aspirin; Brain Ischemia; Cause of Death; Cilostazol; Gastrointestinal Hemorrhage; Huma | 2011 |
[Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].
Topics: Aspirin; Cilostazol; Gastrointestinal Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Ra | 2010 |
3 other studies available for cilostazol and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study.
Topics: Aspirin; Cilostazol; Endoscopic Mucosal Resection; Gastric Mucosa; Gastrointestinal Hemorrhage; Gast | 2023 |
Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhagi | 2023 |
Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Co | 2009 |